4
Changes in Ownership
Perspective Therapeutics, Inc. Filed Acc 0001359820-15-000002
CEO bought 10,000 shares at an average $1.53 ($15,298)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Babcock Dwight William CEO | 2015-06-09 | Purchase | +9,600 | $1.53 | $14,688 | 301,002 | D: show line 1 in the form |
| Babcock Dwight William CEO | 2015-06-09 | Purchase | +100 | $1.53 | $153 | 301,102 | D: show line 2 in the form |
| Babcock Dwight William CEO | 2015-06-09 | Purchase | +300 | $1.53 | $458 | 301,402 | D: show line 3 in the form |
| Open-market purchases · 10,000 sh · avg $1.53 · $15,298 | |||||||
Loading xslF345X03/primary_doc.xml…